Elevated plasma thrombomodulin and angiopoietin-2 predict the development of acute kidney injury in patients with acute myocardial infarction

Critical Care

Volumn 18, Issue 3, 2014, Pages

  Liu, Kuan Liang ^a   Lee, Kuang Tso ^a   Chang, Chih Hsiang ^a   Chen, Yung Chang ^a   Lin, Shu Min ^a   Chu, Pao Hsien ^a  

^a CHANG GUNG UNIVERSITY COLLEGE OF MEDICINE   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANGIOPOIETIN 1; ANGIOPOIETIN 2; ANGIOTENSIN RECEPTOR ANTAGONIST; BIOLOGICAL MARKER; CLOPIDOGREL; CREATINE KINASE MB; CREATININE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; THROMBOMODULIN; VASCULOTROPIN; VON WILLEBRAND FACTOR; THBD PROTEIN, HUMAN;

ACUTE HEART INFARCTION; ACUTE KIDNEY FAILURE; ADULT; AGED; ARTICLE; CELL ACTIVATION; CONTROLLED STUDY; CORONARY ARTERY DISEASE; CREATININE BLOOD LEVEL; ENDOTHELIUM INJURY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GLOMERULUS FILTRATION RATE; HUMAN; MAJOR CLINICAL STUDY; MALE; NON ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; PERCUTANEOUS CORONARY INTERVENTION; PILOT STUDY; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROTEIN BLOOD LEVEL; RECEIVER OPERATING CHARACTERISTIC; ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; VASCULAR STENT; ACUTE KIDNEY INJURY; BLOOD; COMPLICATION; MIDDLE AGED; MYOCARDIAL INFARCTION; PHYSIOLOGY; PREDICTIVE VALUE; VERY ELDERLY;

ACUTE KIDNEY INJURY; AGED; AGED, 80 AND OVER; ANGIOPOIETIN-2; BIOLOGICAL MARKERS; FEMALE; GLOMERULAR FILTRATION RATE; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; PILOT PROJECTS; PREDICTIVE VALUE OF TESTS; PROSPECTIVE STUDIES; THROMBOMODULIN;

EID: 84902485569     PISSN: 13648535     EISSN: 1466609X     Source Type: Journal    
DOI: 10.1186/cc13876     Document Type: Article

References (36)

1. Hsiao PG, Hsieh CA, Yeh CF, Wu HH, Shiu TF, Chen YC, Chu PH. Early prediction of acute kidney injury in patients with acute myocardial injury. J Crit Care 2012, 27:525.
2. Goldberg A, Kogan E, Hammerman H, Markiewicz W, Aronson D. The impact of transient and persistent acute kidney injury on long-term outcomes after acute myocardial infarction. Kidney Int 2009, 76:900-906. 10.1038/ki.2009.295, 19657321.
3. Goldberg A, Hammerman H, Petcherski S, Zdorovyak A, Yalonetsky S, Kapeliovich M, Agmon Y, Markiewicz W, Aronson D. Inhospital and 1-year mortality of patients who develop worsening renal function following acute ST-elevation myocardial infarction. Am Heart J 2005, 150:330-337. 10.1016/j.ahj.2004.09.055, 16086939.
4. Marenzi G, Assanelli E, Campodonico J, De Metrio M, Lauri G, Marana I, Moltrasio M, Rubino M, Veglia F, Montorsi P. Acute kidney injury in ST-segment elevation acute myocardial infarction complicated by cardiogenic shock at admission. Crit Care Med 2010, 38:438. 10.1097/CCM.0b013e3181b9eb3b, 19789449.
5. Parikh CR, Coca SG, Wang Y, Masoudi FA, Krumholz HM. Long-term prognosis of acute kidney injury after acute myocardial infarction. Arch Intern Med 2008, 168:987. 10.1001/archinte.168.9.987, 18474763.
6. Ronco C, Haapio M, House AA, Anavekar N, Bellomo R. Cardiorenal syndrome. J Am Coll Cardiol 2008, 52:1527-1539. 10.1016/j.jacc.2008.07.051, 19007588.
7. Basile DP. The endothelial cell in ischemic acute kidney injury: implications for acute and chronic function. Kidney Int 2007, 72:151-156. 10.1038/sj.ki.5002312, 17495858.
8. Lemieux C, Maliba R, Favier J, Theoret JF, Merhi Y, Sirois MG. Angiopoietins can directly activate endothelial cells and neutrophils to promote proinflammatory responses. Blood 2005, 105:1523-1530. 10.1182/blood-2004-09-3531, 15498854.
9. Lin SM, Wang YM, Lin HC, Lee KY, Huang CD, Liu CY, Wang CH, Kuo HP. Serum thrombomodulin level relates to the clinical course of disseminated intravascular coagulation, multiorgan dysfunction syndrome, and mortality in patients with sepsis. Crit Care Med 2008, 36:683-689. 10.1097/CCM.0B013E31816537D8, 18431261.
10. Maruyama I, Bell CE, Majerus PW. Thrombomodulin is found on endothelium of arteries, veins, capillaries, and lymphatics, and on syncytiotrophoblast of human placenta. J Cell Biol 1985, 101:363-371. 10.1083/jcb.101.2.363, 2113687, 2991298.
11. Takano S, Kimura S, Ohdama S, Aoki N. Plasma thrombomodulin in health and diseases. Blood 1990, 76:2024-2029.
12. Boehme MW, Galle P, Stremmel W. Kinetics of thrombomodulin release and endothelial cell injury by neutrophil-derived proteases and oxygen radicals. Immunology 2002, 107:340-349. 10.1046/j.1365-2567.2002.01469.x, 1782804, 12423310.
13. Chan S-H, Chen J-H, Li Y-H, Lin L-J, Tsai L-M. Increasing post-event plasma thrombomodulin level associates with worse outcome in survival of acute coronary syndrome. Int J Cardiol 2006, 111:280-285. 10.1016/j.ijcard.2005.09.015, 16307806.
14. Kang K, Nan C, Fei D, Meng X, Liu W, Zhang W, Jiang L, Zhao M, Pan S, Zhao M. Heme oxygenase 1 modulates thrombomodulin and endothelial protein C receptor levels to attenuate septic kidney injury. Shock 2013, 40:136-143. 10.1097/SHK.0b013e31829d23f5, 23807243.
15. Wang H, Vinnikov I, Shahzad K, Bock F, Ranjan S, Wolter J, Kashif M, Oh J, Bierhaus A, Nawroth P, Kirschfink M, Conway EM, Madhusudhan T, Isermann B. The lectin-like domain of thrombomodulin ameliorates diabetic glomerulopathy via complement inhibition. Thromb Haemost 2012, 108:1141-1153. 10.1160/TH12-07-0460, 23014597.
16. Asahara T, Chen D, Takahashi T, Fujikawa K, Kearney M, Magner M, Yancopoulos GD, Isner JM. Tie2 receptor ligands, angiopoietin-1 and angiopoietin-2, modulate VEGF-induced postnatal neovascularization. Circ Res 1998, 83:233-240. 10.1161/01.RES.83.3.233, 9710115.
17. van der Heijden M, Pickkers P, van Nieuw Amerongen GP, van Hinsbergh VW, Bouw MP, van der Hoeven JG, Groeneveld AB. Circulating angiopoietin-2 levels in the course of septic shock: relation with fluid balance, pulmonary dysfunction and mortality. Intensive Care Med 2009, 35:1567-1574. 10.1007/s00134-009-1560-y, 2726915, 19551369.
18. Lee KW, Lip GY, Blann AD. Plasma angiopoietin-1, angiopoietin-2, angiopoietin receptor tie-2, and vascular endothelial growth factor levels in acute coronary syndromes. Circulation 2004, 110:2355-2360. 10.1161/01.CIR.0000138112.90641.7F, 15302795.
19. Kumpers P, Hafer C, David S, Hecker H, Lukasz A, Fliser D, Haller H, Kielstein JT, Faulhaber-Walter R. Angiopoietin-2 in patients requiring renal replacement therapy in the ICU: relation to acute kidney injury, multiple organ dysfunction syndrome and outcome. Intensive Care Med 2010, 36:462-470. 10.1007/s00134-009-1726-7, 19956923.
20. Thygesen K, Alpert JS, White HD. Universal definition of myocardial infarction. J Am Coll Cardiol 2007, 50:2173-2195. 10.1016/j.jacc.2007.09.011, 18036459.
21. Mehta RL, Kellum JA, Shah SV, Molitoris BA, Ronco C, Warnock DG, Levin A. Acute Kidney Injury Network: report of an initiative to improve outcomes in acute kidney injury. Crit Care 2007, 11:R31. 10.1186/cc5713, 2206446, 17331245.
22. Levey AS, Coresh J, Greene T, Stevens LA, Zhang YL, Hendriksen S, Kusek JW, Van Lente F. Using standardized serum creatinine values in the modification of diet in renal disease study equation for estimating glomerular filtration rate. Ann Intern Med 2006, 145:247-254. 10.7326/0003-4819-145-4-200608150-00004, 16908915.
23. Kushner FG, Hand M, Smith SC, King SB, Anderson JL, Antman EM, Bailey SR, Bates ER, Blankenship JC, Casey DE. 2009 focused updates: ACC/AHA guidelines for the management of patients with ST-elevation myocardial infarction (updating the 2004 guideline and 2007 focused update) and ACC/AHA/SCAI guidelines on percutaneous coronary intervention (updating the 2005 guideline and 2007 focused update) a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol 2009, 54:2205-2241. 10.1016/j.jacc.2009.10.015, 19942100.
24. Lazzeri C, Valente S, Chiostri M, Picariello C, Attana P, Gensini GF. Microalbuminuria in non-diabetic STEMI: an independent predictor for acute kidney injury. Scand Cardiovasc J 2012, 46:324-329. 10.3109/14017431.2012.702919, 22694718.
25. Mielniczuk LM, Pfeffer MA, Lewis EF, Blazing MA, de Lemos JA, Mohanavelu S, Rouleau J, Fox K, Pedersen TR, Califf RM. Acute decline in renal function, inflammation, and cardiovascular risk after an acute coronary syndrome. Clin J Am Soc Nephrol 2009, 4:1811-1817. 10.2215/CJN.03510509, 2774965, 19820133.
26. Bisoendial RJ, Kastelein JJ, Levels JH, Zwaginga JJ, van den Bogaard B, Reitsma PH, Meijers JC, Hartman D, Levi M, Stroes ES. Activation of inflammation and coagulation after infusion of C-reactive protein in humans. Circ Res 2005, 96:714-716. 10.1161/01.RES.0000163015.67711.AB, 15774855.
27. Yudkin JS, Stehouwer CD, Emeis JJ, Coppack SW. C-reactive protein in healthy subjects: associations with obesity, insulin resistance, and endothelial dysfunction: a potential role for cytokines originating from adipose tissue?. Arterioscler Thromb Vasc Biol 1999, 19:972-978. 10.1161/01.ATV.19.4.972, 10195925.
28. Tang A, Alexiou C, Hsu J, Sheppard SV, Haw MP, Ohri SK. Leukodepletion reduces renal injury in coronary revascularization: a prospective randomized study. Ann Thorac Surg 2002, 74:372-377. 10.1016/S0003-4975(02)03715-3, 12173815.
29. Levi M, Ten Cate H. Disseminated intravascular coagulation. N Engl J Med 1999, 341:586-592. 10.1056/NEJM199908193410807, 10451465.
30. Constans J, Conri C. Circulating markers of endothelial function in cardiovascular disease. Clin Chim Acta 2006, 368:33-47. 10.1016/j.cca.2005.12.030, 16530177.
31. Blann AD, Amiral J, McCollum CN. Prognostic value of increased soluble thrombomodulin and increased soluble E-selectin in ischaemic heart disease. Eur J Haematol 1997, 59:115-120.
32. Olivot JM, Labreuche J, Aiach M, Amarenco P. Soluble thrombomodulin and brain infarction: case-control and prospective study. Stroke 2004, 35:1946-1951. 10.1161/01.STR.0000133340.37712.9b, 15192246.
33. Jaski BE, Cohen JD, Trausch J, Marsh DG, Bail GR, Overlie PA, Skowronski EW, Smith SC. Outcome of urgent percutaneous transluminal coronary angioplasty in acute myocardial infarction: comparison of single-vessel versus multivessel coronary artery disease. Am Heart J 1992, 124:1427-1433. 10.1016/0002-8703(92)90053-X, 1462895.
34. Matijs VM, Kumpers P, Ligtenberg JJM, Meertens JHJM, Molema G, Zijlstra JG. Bench-to-bedside review: angiopoietin signalling in critical illness - a future target?. Crit Care 2009, 13:207. 10.1186/cc7153, 2689450, 19435476.
35. Davis B, Dei Cas A, Long DA, White KE, Hayward A, Ku C-H, Woolf AS, Bilous R, Viberti G, Gnudi L. Podocyte-specific expression of angiopoietin-2 causes proteinuria and apoptosis of glomerular endothelia. J Am Soc Nephrol 2007, 18:2320-2329. 10.1681/ASN.2006101093, 17625119.
36. Eleuteri E, Di Stefano A, Genta FT, Vicari C, Gnemmi I, Colombo M, Mezzani A, Giannuzzi P. Stepwise increase of angiopoietin-2 serum levels is related to haemodynamic and functional impairment in stable chronic heart failure. Eur J Cardiovasc Prev Rehabil 2011, 18:607-614. 10.1177/1741826710389410, 21450636.